RA Capital Management, L.P. 13D and 13G filings for Vor Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-30 6:51 pm Purchase | 2024-12-26 | 13D | Vor Biopharma Inc. VOR | RA Capital Management, L.P. | 39,709,850 31.900% | 16,929,507 (+74.32%) | Filing |
| 2023-08-11 5:05 pm Purchase | 2023-08-10 | 13D | Vor Biopharma Inc. VOR | RA Capital Management, L.P. | 22,780,343 33.700% | 20,198 (+0.09%) | Filing |
| 2022-12-09 4:31 pm Purchase | 2022-12-07 | 13D | Vor Biopharma Inc. VOR | RA Capital Management, L.P. | 22,760,145 34.800% | 11,628,845 (+104.47%) | Filing |
| 2022-11-14 4:46 pm Purchase | 2022-11-10 | 13D | Vor Biopharma Inc. VOR | RA Capital Management, L.P. | 11,131,300 28.780% | 10,327 (+0.09%) | Filing |
| 2021-02-19 4:30 pm Purchase | 2021-02-09 | 13D | Vor Biopharma Inc. VOR | RA Capital Management, L.P. | 11,120,973 30.000% | 11,120,973 (New Position) | Filing |